Delaware
|
001-37568
|
26-4231384
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
300 Connell Drive, Suite 4000
Berkeley Heights, NJ
|
07922
|
|
(Address of principal executive offices)
|
(Zip Code)
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 9.01.
|
Financial Statements and Exhibits.
|
Exhibit
Number
|
Description of Document
|
Incorporated by Reference
|
|||
Schedule/
Form
|
File
Number
|
Exhibits
|
Filing Date
|
||
Agreement and Plan of Merger and Reorganization, dated November 23, 2018, by and among Edge Therapeutics, Inc., PDS Biotechnology Corporation and
Echos Merger Sub, Inc.
|
Form 8-K
|
001-37568
|
Exhibit 2.1
|
November 26, 2018
|
|
Amendment No. 1 to Agreement and Plan of Merger and Reorganization dated January 24, 2019, by and among Edge Therapeutics, Inc., PDS Biotechnology
Corporation and Echos Merger Sub, Inc.
|
Form 8-K
|
001-37568
|
Exhibit 2.1
|
January 30, 2019
|
|
Certificate of Amendment to Restated Certificate of Incorporation.
|
Form 8-K
|
001-37568
|
Exhibit 3.1
|
March 18, 2019
|
|
Certificate of Amendment to Restated Certificate of Incorporation.
|
Form 8-K
|
001-37568
|
Exhibit 3.2
|
March 18, 2019
|
|
Consent of Haynie & Company, Private PDS’s independent registered public accounting firm.
|
|||||
Press release issued by Edge Therapeutics, Inc. and PDS Biotechnology Corporation, dated March 18, 2019.
|
Form 8-K
|
001-37568
|
Exhibit 99.1
|
March 18, 2019
|
|
Audited financial statements of Private PDS as of and for the years ended December 31, 2018 and 2017.
|
*
|
Filed herewith
|
PDS Biotechnology Corporation
|
||
Dated: April 30, 2019
|
||
By:
|
/s/ Frank Bedu-Addo
|
|
Name:
|
Frank Bedu-Addo
|
|
Title:
|
President and Chief Executive Officer
|